In insulin-naive T2D, fixed-dose weekly efsitora was noninferior to daily glargine for reducing HbA<sub>1c</sub> at 52 wk

Authors

Institutions

Publication Details

Journal
Annals of Internal Medicine
Published
2025-10-01
DOI
https://doi.org/10.7326/annals-25-03845-jc
Primary Topic
Diabetes Management and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

In insulin-naive T2D, fixed-dose weekly efsitora was noninferior to daily glargine for reducing HbA1c at 52 wk

Michael C. Tanner
Annals of Internal Medicine
Diabetes Management and Research
article

In insulin-naive T2D, fixed-dose weekly efsitora was noninferior to daily glargine for reducing HbA1c at 52 wk

Michael C. Tanner
article en

Abstract

No abstract available for this paper.
Annals of Internal MedicineVol. 178(10)
New York University (US)
Openalex Percentile: Top 63%
Diabetes Management and Research
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

In insulin-naive T2D, fixed-dose weekly efsitora was noninferior to daily glargine for reducing HbA<sub>1c</sub> at 52 wk — Michael C. Tanner · Annals of Internal Medicine (2025) | TGRS Research Map | TGRS